Skip to main content
NeuroRx logoLink to NeuroRx
editorial
. 2012 Sep 5;3(2):131–132. doi: 10.1016/j.nurx.2006.02.001

Pediatric neurotherapy

Leon S Dure 1,✉, Faye Silverstein
PMCID: PMC3593439  PMID: 23483855

The content is available as a PDF (47.7 KB).

Contributor Information

Leon S. Dure, Email: ldure@peds.uab.edu

Faye Silverstein, Email: fsilvers@med.umich.edu.

References

  • 1.Kirton A, deVeber G. Therapeutic approaches and advances in pédiatric stroke. NeuroRx. 2006;3:133–142. doi: 10.1016/j.nurx.2006.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Potts MB, Koh S-E, Whetstone WD, Walker BA, Yoneyama T, Claus CP, et al. Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets. NeuroRx. 2006;3:143–153. doi: 10.1016/j.nurx.2006.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx. 2006;3:154–168. doi: 10.1016/j.nurx.2006.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Donner EJ, Snead OC. New generation anticonvulsants for the treatment of epilepsy in children. NeuroRx. 2006;3:170–180. doi: 10.1016/j.nurx.2006.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lewis DW. The pharmacological treatment options for pediatric migraine: an evidence-based appraisal. NeuroRx. 2006;3:181–191. doi: 10.1016/j.nurx.2006.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Scahill L, Erenberg G, Berlin CM, Budman C, Coffey BJ, Jankovic J, et al. Contemporary assessment and pharmacotherapy of tourette syndrome. NeuroRx. 2006;3:192–206. doi: 10.1016/j.nurx.2006.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Filipek PA, Steinberg-Epstein R, Book TM. Intervention for autistic spectrum disorders. NeuroRx. 2006;3:207–216. doi: 10.1016/j.nurx.2006.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tilton AH. Therapeutic interventions for tone abnormalities in cerebral palsy. NeuroRx. 2006;3:217–224. doi: 10.1016/j.nurx.2006.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Strober JB. Therapeutics in Duchenne muscular dystrophy. NeuroRx. 2006;3:225–234. doi: 10.1016/j.nurx.2006.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Summer CJ. Therapeutics development for spinal muscular atrophy. NeuroRx. 2006;3:235–245. doi: 10.1016/j.nurx.2006.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Moser HW. Therapy of x-linked adrenoleukodystrophy. NeuroRx. 2006;3:246–253. doi: 10.1016/j.nurx.2006.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Eklund EA, Freeze HH. The congenital disorders of glycosylation—a multifaceted group of syndromes. NeuroRx. 2006;3:254–263. doi: 10.1016/j.nurx.2006.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chabas D, Green AJ, Waubant E. Pediatric multiple sclerosis. NeuroRx. 2006;3:264–275. doi: 10.1016/j.nurx.2006.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Robertson PL. Advances in treatment of pediatric brain tumors. NeuroRx. 2006;3:276–291. doi: 10.1016/j.nurx.2006.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from NeuroRx are provided here courtesy of Am. Soc. for Experimental NeuroTherapeutics

RESOURCES